Digital medicine company Akili has added Meghan Rivera to its executive team in the newly created role of Chief Marketing Officer. In her role, Ms. Rivera will oversee the marketing and sales of Akili’s first commercial product, EndeavorRx.
“Meghan is an innovative leader with a history of executing disruptive marketing and commercial strategies,” said Akili Chief Executive Officer, Dr. Eddie Martucci. “As we make the transition to a commercial organization at Akili, her focus on results and passion for bringing the voice of the customer to healthcare will serve us well as we continue to push the boundaries of medicine and create amazing experiences for patients and their families.”
Ms. Rivera has more than 20 years of experience in digital marketing, most recently as leader of AMAG Pharmaceuticals’ women’s health business. She was named the 2012 “Rising Star” award by the Healthcare Women Association and the 2015 PM360 ELITE Transformational Leader, and in 2018 was inducted into the MM&M “Hall of Femme.”
“I’m thrilled to join the team at Akili where we are defying convention and changing the way the world experiences medicine,” said Ms. Rivera. “EndeavorRx™ represents the next generation of digital therapeutics, but it is only the beginning. I look forward to our continuing to challenge the status quo in healthcare and helping and connecting with patients in ways we never before imagined.”